HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTLMichiko Harao, Yasuharu Nishimura, Kumiko Harada et al.|International Journal of Cancer|2008Cited by 92
A novel tumor‐associated antigen, cell division cycle 45‐like can induce cytotoxic T‐lymphocytes reactive to tumor cellsYusuke Tomita, Yasuharu Nishimura, Katsunori Imai et al.|Cancer Science|2011Cited by 46
The forkhead box M1 transcription factor as a candidate of target for anti‐cancer immunotherapyKazunori Yokomine, Yasuharu Nishimura, Satoru Senju et al.|International Journal of Cancer|2009Cited by 40
Identification of SPARC as a candidate target antigen for immunotherapy of various cancersMitsuhiro Inoue, Yasuharu Nishimura, Satoru Senju et al.|International Journal of Cancer|2010Cited by 39
Identification of immunogenic LY6K long peptide encompassing both CD4<sup>+</sup>and CD8<sup>+</sup>T-cell epitopes and eliciting CD4<sup>+</sup>T-cell immunity in patients with malignant diseaseYusuke Tomita, Yasuharu Nishimura, Akira Yuno et al.|OncoImmunology|2014Cited by 17